136 related articles for article (PubMed ID: 36979880)
21. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
[TBL] [Abstract][Full Text] [Related]
22. Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 Variant.
Cocherie T; Bastide M; Sakhi S; Zafilaza K; Flandre P; Leducq V; Jary A; Burrel S; Louet M; Calvez V; Marcelin AG; Marot S
Microbiol Spectr; 2022 Oct; 10(5):e0192222. PubMed ID: 36125269
[TBL] [Abstract][Full Text] [Related]
23. Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2.
Zhang J; Zhao D; Hu J; Huang X; Gu Q; Tao Z
Front Public Health; 2022; 10():1049006. PubMed ID: 36466505
[TBL] [Abstract][Full Text] [Related]
24. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
[TBL] [Abstract][Full Text] [Related]
25. Lung tropism in hospitalized patients following infection with SARS-CoV-2 variants from D614G to Omicron BA.2.
Hirotsu Y; Kakizaki Y; Saito A; Tsutsui T; Hanawa S; Yamaki H; Ide S; Kawaguchi M; Kobayashi H; Miyashita Y; Omata M
Commun Med (Lond); 2023 Feb; 3(1):32. PubMed ID: 36841870
[TBL] [Abstract][Full Text] [Related]
26. Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study.
Lauring AS; Tenforde MW; Chappell JD; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Exline MC; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Halasa N; Grijalva CG; Rice TW; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Adams K; Schrag SJ; Olson SM; Kobayashi M; Verani JR; Patel MM; Self WH;
medRxiv; 2022 Feb; ():. PubMed ID: 35169811
[TBL] [Abstract][Full Text] [Related]
27. Computed Tomographic Imaging Features of COVID-19 Pneumonia Caused by the Delta (B.1.617.2) and Omicron (B.1.1.529) Variant in a German Nested Cohort Pilot Study Group.
Askani E; Mueller-Peltzer K; Madrid J; Knoke M; Hasic D; Bamberg F; Schlett CL; Agarwal P
Tomography; 2022 Sep; 8(5):2435-2449. PubMed ID: 36287801
[TBL] [Abstract][Full Text] [Related]
28. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
[TBL] [Abstract][Full Text] [Related]
29. The Omicron variant BA.1.1 presents a lower pathogenicity than B.1 D614G and Delta variants in a feline model of SARS-CoV-2 infection.
Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
bioRxiv; 2022 Jun; ():. PubMed ID: 35734088
[TBL] [Abstract][Full Text] [Related]
30. Immunity against Delta and Omicron variants elicited by homologous inactivated vaccine booster in kidney transplant recipients.
Zhang L; Yang J; Lai C; Wan L; Xiong S; Kong W; Liu Z; Yu P; Chen M; Mai W; Khan SA; Deng M; Chen L; Lei Y; Zhou Q; Yu N; Li P; Chen Z; Ji T
Front Immunol; 2022; 13():1042784. PubMed ID: 36700230
[TBL] [Abstract][Full Text] [Related]
31. Chest CT features of children infected by B.1.617.2 (Delta) variant of COVID-19.
Cheng QR; Fan MX; Hao J; Hu XC; Ge XH; Hu ZL; Li Z
World J Pediatr; 2022 Jan; 18(1):37-42. PubMed ID: 34811704
[TBL] [Abstract][Full Text] [Related]
32. Clinical and radiological characteristics of pediatric COVID-19 before and after the Omicron outbreak: a multi-center study.
Lin B; Xu X; Shen Z; Huang P; Gao Y; Liu J; Xie Z; Zhao T; Xia J; Lv J; Ren D; Zheng H; Wang X; Hu M; Ruan G; Zhang M
Front Pediatr; 2023; 11():1172111. PubMed ID: 37664548
[TBL] [Abstract][Full Text] [Related]
33. Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea.
Choi SH; Choi JH; Lee JK; Eun BW; Song SH; Ahn B; Kim YK; Yun KW
J Korean Med Sci; 2023 Mar; 38(9):e65. PubMed ID: 36880106
[TBL] [Abstract][Full Text] [Related]
34. Clinical features and predictive factors related to liver injury in SARS-CoV-2 Delta and Omicron variant-infected patients.
Deng H; Lin H; Mai Y; Liu H; Chen W
Eur J Gastroenterol Hepatol; 2022 Sep; 34(9):933-939. PubMed ID: 35482929
[TBL] [Abstract][Full Text] [Related]
35. Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age.
Khan FL; Nguyen JL; Singh TG; Puzniak LA; Wiemken TL; Schrecker JP; Taitel MS; Zamparo JM; Jodar L; McLaughlin JM
JAMA Netw Open; 2022 Dec; 5(12):e2246915. PubMed ID: 36515946
[TBL] [Abstract][Full Text] [Related]
36. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial.
Zhang Y; Ma X; Yan G; Wu Y; Chen Y; Zhou Z; Wan N; Su W; Liu FW; Dai MX; Yang M; Li C; Yu X; Zhang L; Wang Z; Zhou TC; You D; Wei J; Zhang Z;
EClinicalMedicine; 2022 Dec; 54():101680. PubMed ID: 36188435
[TBL] [Abstract][Full Text] [Related]
38. Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents.
Ma C; Chen X; Mei F; Xiong Q; Liu Q; Dong L; Liu C; Zou W; Zhan F; Hu B; Liu Y; Liu F; Zhou L; Xu J; Jiang Y; Xu K; Cai K; Chen Y; Yan H; Lan K
Emerg Microbes Infect; 2022 Dec; 11(1):567-572. PubMed ID: 35060426
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 Variants Infection in Relationship to Imaging-based Pneumonia and Clinical Outcomes.
Lee JE; Hwang M; Kim YH; Chung MJ; Sim BH; Jeong WG; Jeong YJ
Radiology; 2023 Mar; 306(3):e221795. PubMed ID: 36165791
[TBL] [Abstract][Full Text] [Related]
40. Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules.
Choi JY; Lee YJ; Ko JH; Kim SH; Kim HJ; Lee HW; Jeong H; Kim TY; Jang YG; Hong HJ; Kim MS; Lee SE; Kim YG; Chung EJ; Lim H; Jang S; Kim K; Kim SS; Ahn JY; Choi JY; Kim YC; Park YS; Peck KR; Kim B
Front Cell Infect Microbiol; 2022; 12():948014. PubMed ID: 35899050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
